|
Real-time Estimate
Cboe BZX
10:26:29 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.765 USD | -3.02% |
|
-7.37% | +53.04% |
| Market Cap | 81Cr 72Cr 67Cr 61Cr 115.35Cr 7.8TCr 116.2Cr 813.27Cr 316.41Cr 3.98TCr 304.01Cr 297.45Cr 13TCr | P/E 2026 * |
-10.7x | P/E 2027 * | -9.1x |
|---|---|---|---|---|---|
| Enterprise Value | 81Cr 72Cr 67Cr 61Cr 115.35Cr 7.8TCr 116.2Cr 813.27Cr 316.41Cr 3.98TCr 304.01Cr 297.45Cr 13TCr | EV / Sales 2026 * |
21.8x | EV / Sales 2027 * | 47.8x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LXRX | Delayed | |
CBOE
| LXRX | Real-time | |
|
Tradegate
| LX31 | Real-time |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | -3.02% | ||
| 1 week | -7.37% | ||
| Current month | -6.13% | ||
| 1 month | -21.08% | ||
| 3 months | -24.14% | ||
| 6 months | +10.69% | ||
| Current year | +53.04% |
| 1 week | 1.75 |  | 1.95 |
| 1 month | 1.75 | | 2.25 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% | ||
| 03/06/26 | Exercice | Director | 1,78,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.02% | -7.37% | +13.55% | +67.62% | 81Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -0.37% | -3.81% | +19.51% | +78.12% | 5.74TCr | |
| +1.63% | -1.61% | +3.16% | +36.89% | 4.76TCr | |
| -0.13% | +1.95% | +341.55% | +714.23% | 4.43TCr | |
| +1.84% | -2.89% | +28.35% | +33.02% | 4.25TCr | |
| +0.52% | -1.92% | +4.48% | +110.92% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +54.06% | 3.1TCr | |
| +1.56% | +4.53% | +31.34% | +26.92% | 2.85TCr | |
| +0.38% | -1.81% | -7.49% | -11.44% | 2.43TCr | |
| Average | +0.59% | -0.39% | +49.31% | +120.45% | 3.91TCr | |
| Weighted average by Cap. | +1.24% | -0.84% | +57.39% | +135.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72Cr 3.32Cr 3.09Cr 2.81Cr 5.29Cr 357.93Cr 5.33Cr 37Cr 15Cr 182.68Cr 14Cr 14Cr 587.2Cr | 1.69Cr 1.51Cr 1.41Cr 1.28Cr 2.41Cr 163.09Cr 2.43Cr 17Cr 6.62Cr 83Cr 6.36Cr 6.22Cr 267.56Cr |
| Net income | -7.38Cr -6.58Cr -6.13Cr -5.58Cr -11Cr -710.43Cr -11Cr -74Cr -29Cr -362.59Cr -28Cr -27Cr -1.17TCr | -9.7Cr -8.66Cr -8.07Cr -7.34Cr -14Cr -934.66Cr -14Cr -97Cr -38Cr -477.04Cr -36Cr -36Cr -1.53TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $1.760 | -3.30% | 5,60,400 |
| 02/26/02 | $1.820 | 0.00% | 23,17,716 |
| 01/26/01 | $1.820 | -2.93% | 22,73,032 |
| 30/26/30 | $1.875 | -0.27% | 17,44,199 |
| 29/26/29 | $1.880 | -1.05% | 39,46,250 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
